A recent scare headline from CNN proclaimed that "a small glass of juice or soda a day is linked to increased risk of cancer, study finds." Ooh! That's really bad. Or it is? So many dietary studies turn out to be nonsense; they are the product of flawed observational studies. How about this one? Angela Dowden lets us know.

ACSH friend Dr. Aric Hausknecht takes issue with the July 4th advice tweeted by Surgeon General Jerome Adams, which recommended the use of IV Tylenol for post-operative pain. The New York neurologist and pain management physician gave us exclusive permission to print his response to Dr. Adams.

A Virginia news report states that two people died and 18 are hospitalized following an outbreak of an unknown respiratory infection at a retirement community. It's probably not influenza, but answers as to the cause are elusive.

Our reaction time slows as we age, a study suggests that increasingly autonomous cars can make driving safer for older drivers and the people surrounding them. Yogi Berra sums it up, "In theory, there is no difference between theory and practice. In practice, there is."

In 2017, the CDC recorded 2,813,503 deaths in the United States. That's an average of 7,708 per day. But averages can be misleading. While that's the average, there is wide variability depending on the time of year. Specifically, people are far likelier to die during one extreme temperature season than the other.

A new study shows physicians "over-prescribing" the length of treatment for pneumonia. We seem to restart therapy at discharge.

Identifying the cause of an infectious disease is time-consuming and not always easy. So a company called Karius has developed a blood test that analyzes cell-free DNA to identify more than a thousand pathogens.

Nomenclature -- the "art" of naming organic chemicals -- is crazy making. Some chemical names are simple. Some are complex. What's more, saying the names of some chemicals makes you sound like a fourth grader. (And if that's not enough of a pull to get you to read this, there's a contest, too!)

The opioid crisis has its villains, physicians, Big Pharma and illicit fentanyl. But an economic lens points to another driving force: Trade policy?

Curing cancer is a misleading term. Cancer is far too complex to be treated as a single disease. Doing so would be akin to coming up with a pill that cures all viral infections -- something that's all but impossible. In his second of a multi-part series on the issues and obstacles facing cancer researchers, our new Senior Fellow Dr. Chris Gerry discusses the multiple challenges that must be overcome, and a new paradigm for treating the disease at the genetic level.